Endokrynol Pol
| WoS 期刊 JCR 分区 (2026 · JIF) | 综合 SCIE | Q3 | ||
|---|---|---|---|---|
| 学科 | 收录集 | JIF 分区 | JIF 排名 | JIF 百分位 |
| 内分泌学与代谢 Endocrinology & Metabolism | SCIE | Q3 | 145/198 |
26.8%
|
| 学科 | 收录集 | JCI 分区 | JCI 排名 | JCI 百分位 |
|---|---|---|---|---|
| 内分泌学与代谢 Endocrinology & Metabolism | SCIE | Q4 | 125/161 JCI 0.45 |
23.0%
|
Endokrynologia Polska (abbreviated as Endokrynol Pol) is a peer-reviewed scientific journal dedicated to the field of endocrinology. Published by the Polish Society of Endocrinology, the journal serves as a key platform for disseminating clinical and experimental research in this specialized medical discipline. Its scope encompasses a broad range of topics, including thyroid disorders, diabetes mellitus, pituitary and adrenal diseases, neuroendocrinology, reproductive endocrinology, metabolic bone disease, and hormonal aspects of oncology. The journal primarily publishes original research articles, comprehensive review articles, and concise clinical case reports, with occasional editorials and letters to the editor that stimulate academic discourse. The target audience includes endocrinologists, diabetologists, internal medicine specialists, and researchers in metabolic and hormonal sciences. Endokrynologia Polska is an open-access journal, ensuring that all published content is freely available to readers worldwide, which enhances the visibility and dissemination of its scientific contributions. With a 2026 Impact Factor of 2.2000, the journal is ranked in the JCR Q3 quartile, placing it within the lower-middle tier of endocrinology journals globally. While not among the highest-impact titles in the field, its consistent indexing and regional influence make it a noteworthy resource for clinicians and researchers, particularly those focused on Central and Eastern European endocrinological practice and research.